title: Increased glutathione synthesis associated with platelet-derived growth factor stimulation of NIH3T3 fibroblasts.
abstract: Previous data show a relation between GSH content and proliferation of normal and tumour cells. We recently demonstrated a specific involvement of GSH in the autophosphorylation activity of the platelet-derived growth factor (PDGF) receptor in NIH3T3 fibroblasts. In this study we demonstrate that the stimulation by PDGF of serum-starved NIH3T3 cells increases cellular GSH content, while no change in oxidized GSH content was measured. Experiments performed with actinomycin, cycloheximide and buthionine sulfoximide, a specific inhibitor of the rate-limiting enzyme of the de novo synthesis of GSH gamma-glutamylcysteine synthetase (gamma-GCS), confirm PDGF induction of GSH synthesis. These results provide the first demonstration that PDGF mediated transduction signals seem strictly related to mechanisms involved in the increase of gamma-GCS activity associated with increased gamma-GCS heavy subunit mRNA levels. In fact, serum and epidermal growth factor (EGF) stimulation of quiescent NIH3T3 and NIH3T3, which overexpress EGF receptor, does not affect GSH content or its synthesis. These data may be related to a possible GSH role in the redox regulation of cell proliferation mediated by PDGF.
authors.affiliation: Department of Biochemical Sciences, University of Florence, viale Morgagni 50, 50134, Florence, Italy.
authors.forename: T
authors.initials: T
authors.lastname: Iantomasi
authors.forename: F
authors.initials: F
authors.lastname: Favilli
authors.forename: D
authors.initials: D
authors.lastname: Degl'Innocenti
authors.forename: M T
authors.initials: MT
authors.lastname: Vincenzini
mesh_terms: D016475:3T3 Cells; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D005978:Glutathione / Q000096:biosynthesis*; D019803:Glutathione Disulfide / Q000032:analysis; D008298:Maleates / Q000494:pharmacology; D051379:Mice; D010084:Oxidation-Reduction; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D017479:Receptors, Platelet-Derived Growth Factor / Q000187:drug effects
chemical_list: D008298:Maleates; D010982:Platelet-Derived Growth Factor; D003609:Dactinomycin; D003513:Cycloheximide; D017479:Receptors, Platelet-Derived Growth Factor; C014476:diethyl maleate; D005978:Glutathione; D019803:Glutathione Disulfide